AANEM News Express

AANEM News Express

Clinical Characteristics of Patients with Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

11/30/2016
 
Cortes-Vicente E, Gallardo E, Martinez M, et al. Clinical Characteristics of Patients with Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin. JAMA Neurol 2016;73:1099-1104.

Submitted by Rocio (Carolina) Garcia, MD, News Science Editorial Board
The objective of this restrospective cohort study of patients with myasthenia gravis was to determine the characteristics of patients negative for both acetylcholine receptor antibodies (AchR Ab) and MuSK antibodies and positive for cortactin antibodies and compare them with seropositive patients. A total of 250 patients were included; 80% (201) were AchR-Ab positive, 4.4% (11) were MUSK-Ab positive and 15.2% (38) were double seronegative. Nine out of the 38 double seronegative patients were positive for cortactin antibodies. These patients tended to be younger than those with AChR Ab myasthenia gravis and had milder disease: none of the cortactin positive patients had bulbar symptoms, six had pure ocular symptoms, and three had mildly generalized myasthenia gravis.

Comment: Cortactin is a post synaptic neuromuscular junction protein involved in acetylcholine receptor clustering. Though not yet proven to be pathogenic, antibodies to cortactin can be added to the list of antibodies described in patients with double seronegative myasthenia gravis LRP4, agrin, and Dok-7 subgroup. The milder disease phenotype in patients with cortactin antibodies needs to be confirmed in larger samples.

About the AANEM News Science Editorial Board

The board helps to highlight significant, timely science news items for AANEM members. It reviews articles in journals and websites, identifies newsworthy items in the field, and writes article summaries.
 


View Related News Stories:

  Practice


Recent AANEM News

Science News: Role of Ultrasonography in Severe Distal Median Nerve Neuropathy

Received a Solicitation for EDX Services? Send it to AANEM

Science News: Shared Polygenic Risk and Causal Inferences in Amyotrophic Lateral Sclerosis

Exciting Workshops Coming to 2019 AANEM Annual Meeting

AANEM Announces 2019 Achievement Award Winners





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job